Antioxidant effect of adrenomedullin on angiotensin II-induced reactive oxygen species generation in vascular smooth muscle cells

Endocrinology

Volumn 145, Issue 7, 2004, Pages 3331-3337

  Yoshimoto, Takanobu ^a   Fukai, Nozomi ^a   Sato, Ryuji ^a   Sugiyama, Toru ^a   Ozawa, Naoko ^a   Shichiri, Masayoshi ^a   Hirata, Yukio ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADRENOMEDULLIN; ANGIOTENSIN; ANTIOXIDANT; CALCITONIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DICHLOROFLUORESCEIN; ENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; PEPTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; RECEPTOR BLOCKING AGENT; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; SULFONAMIDE; SYNAPSIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL INJURY; GENE EXPRESSION; MEASUREMENT; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ADRENOMEDULLIN; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; AORTA, THORACIC; CELLS, CULTURED; CHEMOKINE CCL2; CYCLIC AMP-DEPENDENT PROTEIN KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NADH, NADPH OXIDOREDUCTASES; OXIDATION-REDUCTION; PEPTIDES; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, PEPTIDE; RNA, MESSENGER; VASOCONSTRICTOR AGENTS;

EID: 3042638614     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1583     Document Type: Article

References (49)

1. Griendling KK, Sorescu D, Ushio-Fukai M 2000 NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86:494-501
2. Alexander RW 1995 Theodore Cooper Memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25:155-161
3. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T 1995 Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270:296-299
4. Mohazzab KM, Kaminski PM, Wolin MS 1994 NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266:H2568-H2572
5. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW 1994 Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:1141-1148
6. De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, Griendling KK 1998 Tumour necrosis factor a activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 329:653-657
7. Matsubara T, Ziff M 1986 Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 137:3295-3298
8. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M 2000 Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20:2175-2183
9. Kunsch C, Medford RM 1999 Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85:753-766
10. Berk BC, Corson MA 1997 Angiotensin II signal transduction in vascular smooth muscle: role of tyrosine kinases. Circ Res 80:607-616
11. Eguchi S, Inagami T 2000 Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 91:13-20
12. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK 1996 p22phox Is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271:23317-23321
13. Frank GD, Eguchi S, Inagami T, Motley ED 2001 N-acetylcysteine inhibits angiotensin II-mediated activation of extracellular signal-regulated kinase and epidermal growth factor receptor. Biochem Biophys Res Commun 280:1116-1119
14. Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RM 1998 Angiotensin II induces monocyte chemoattractant protein-1 gene expression in rat vascular smooth muscle cells. Circ Res 83:952-959
15. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T 1993 Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553-560
16. Minamino N, Kikumoto K, Isumi Y 2002 Regulation of adrenomedullin expression and release. Microsc Res Tech 57:28-39
17. Shichiri M, Fukai N, Ozawa N, Iwasaki H, Hirata Y 2003 Adrenomedullin is an autocrine/paracrine growth factor for rat vascular smooth muscle cells. Regul Pept 112:167-173
18. Iwasaki H, Eguchi S, Shichiri M, Marumo F, Hirata Y 1998 Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology 139:3432-3441
19. Horio T, Kohno M, Kano H, Ikeda M, Yasunari K, Yokokawa K, Minami M, Takeda T 1995 Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 77:660-664
20. Fukai N, Shichiri M, Ozawa N, Matsushita M, Hirata Y 2003 Coexpression of calcitonin receptor-like receptor and receptor activity-modifying protein 2 or 3 mediates the antimigratory effect of adrenomedullin. Endocrinology 144:447-453
21. Kato H, Shichiri M, Marumo F, Hirata Y 1997 Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 138:2615-2620
22. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, Marumo F 1996 Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 81:1449-1453
23. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H 1995 Interleukin-1, tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 207:25-32
24. Kim W, Moon SO, Sung MJ, Kim SH, Lee S, So JN, Park SK 2003 Angiogenic role of adrenomedullin through activation of Akt, mitogen-activated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J 17:1937-1939
25. Nussdorfer GG, Rossi GP, Mazzocchi G 1997 Role of adrenomedullin and related peptides in the regulation of the hypothalamo-pituitary-adrenal axis. Peptides 18:1079-1089
26. Shimosawa T, Shibagaki Y, Ishibashi K, Kitamura K, Kangawa K, Kato S, Ando K, Fujita T 2002 Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 105:106-111
27. Touyz RM, Schiffrin EL 1999 Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 34:976-982
28. Su B, Mitra S, Gregg H, Flavahan S, Chotani MA, Clark KR, Goldschmidt-Clermont PJ, Flavahan NA 2001 Redox regulation of vascular smooth muscle cell differentiation. Circ Res 89:39-46
29. Liu H, Palmer D, Jimmo SL, Tilley DG, Dunkerley HA, Pang SC, Maurice DH 2000 Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells. J Biol Chem 275:26615-26624
30. Yoshimoto T, Naruse M, Naruse K, Shionoya K, Tanaka M, Tanabe A, Hagiwara H, Hirose S, Muraki T, Demura H 1996 Angiotensin II-dependent down-regulation of vascular natriuretic peptide type C receptor gene expression in hypertensive rats. Endocrinology 137:1102-1107
31. Iwasaki H, Yoshimoto T, Sugiyama T, Hirata Y 2003 Activation of cell adhesion kinase β by mechanical stretch in vascular smooth muscle cells. Endocrinology 144:2304-2310
32. Shichiri M, Hirata Y 2001 Antiangiogenesis signals by endostatin. FASEB J 15:1044-1053
33. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK 1998 p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II. Role in vascular smooth muscle cell hypertrophy. J Biol Chem 273:15022-15029
34. Viedt C, Soto U, Krieger-Brauer HI, Fei J, Elsing C, Kubler W, Kreuzer J 2000 Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 20:940-948
35. Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, Ogawa S 2001 ERK and p38 MAPK, but not NF-κB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II in cardiac fibroblasts. Circ Res 89:661-669
36. Swiatkowska M, Szemraj J, Al-Nedawi KN, Pawlowska Z 2002 Reactive oxygen species upregulate expression of PAI-1 in endothelial cells. Cell Mol Biol Lett 7:1065-1071
37. Tummala PE, Chen XL, Sundell CL, Laursen JB, Hammes CP, Alexander RW, Harrison DG, Medford RM 1999 Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 100:1223-1229
38. Suzuki M, Akimoto K, Hattori Y 2002 Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells. Life Sci 72:59-66
39. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK 2001 Novel gp91(phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88:888-894
40. Lassegue B, Clempus RE 2003 Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285:R277-R297
41. Fridovich I 1997 Superoxide anion radical (O2-.), superoxide dismutases, and related matters. J Biol Chem 272:18515-18517
42. Kato K, Yin H, Agata J, Yoshida H, Chao L, Chao J 2003 Adrenomedullin gene delivery attenuates myocardial infarction and apoptosis after ischemia and reperfusion. Am J Physiol Heart Circ Physiol 285:H1506-H1514
43. Eguchi S, Iwasaki H, Inagami T, Numaguchi K, Yamakawa T, Motley ED, Owada KM, Marumo F, Hirata Y 1999 Involvement of Pyk2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension 33:201-206
44. Iwasaki H, Shichiri M, Marumo F, Hirata Y 2001 Adrenomedullin stimulates proline-rich tyrosine kinase 2 in vascular smooth muscle cells. Endocrinology 142:564-572
45. Chen XL, Zhang Q, Zhao R, Ding X, Tummala PE, Medford RM 2003 Racl and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-α in endothelial cells. J Pharmacol Exp Ther 305:573-580
46. Ahn JD, Morishita R, Kaneda Y, Lee KU, Park JY, Jeon YJ, Song HS, Lee IK 2001 Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells. Diabetologia 44:713-720
47. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12:2005-2015
48. Gomez del Arco P, Martinez-Martinez S, Calvo V, Armesilla AL, Redondo JM 1997 Antioxidants and AP-1 activation: a brief overview. Immunobiology 198:273-278
49. Shimosawa T, Ogihara T, Matsui H, Asano T, Ando K, Fujita T 2003 Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension 41:1080-1085